Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

29 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Mirtazapine versus other antidepressants in the acute-phase treatment of adults with major depression: systematic review and meta-analysis.
Watanabe N, Omori IM, Nakagawa A, Cipriani A, Barbui C, McGuire H, Churchill R, Furukawa TA; Multiple Meta-Analyses of New Generation Antidepressants (MANGA) Study Group. Watanabe N, et al. Among authors: omori im. J Clin Psychiatry. 2008 Sep;69(9):1404-15. doi: 10.4088/jcp.v69n0908. J Clin Psychiatry. 2008. PMID: 19193341 Review.
Safety reporting and adverse-event profile of mirtazapine described in randomized controlled trials in comparison with other classes of antidepressants in the acute-phase treatment of adults with depression: systematic review and meta-analysis.
Watanabe N, Omori IM, Nakagawa A, Cipriani A, Barbui C, McGuire H, Churchill R, Furukawa TA; MANGA (Meta-Analysis of New Generation Antidepressants) Study Group. Watanabe N, et al. Among authors: omori im. CNS Drugs. 2010 Jan;24(1):35-53. doi: 10.2165/11319480-000000000-00000. CNS Drugs. 2010. PMID: 20030418 Review.
Mirtazapine versus other antidepressive agents for depression.
Watanabe N, Omori IM, Nakagawa A, Cipriani A, Barbui C, Churchill R, Furukawa TA. Watanabe N, et al. Among authors: omori im. Cochrane Database Syst Rev. 2011 Dec 7;(12):CD006528. doi: 10.1002/14651858.CD006528.pub2. Cochrane Database Syst Rev. 2011. PMID: 22161405 Free PMC article. Review.
Efficacy and tolerability of milnacipran in the treatment of major depression in comparison with other antidepressants : a systematic review and meta-analysis.
Nakagawa A, Watanabe N, Omori IM, Barbui C, Cipriani A, McGuire H, Churchill R, Furukawa TA; Multiple Meta-Analyses of New-Generation Antidepressants (MANGA) Study Group. Nakagawa A, et al. Among authors: omori im. CNS Drugs. 2008;22(7):587-602. doi: 10.2165/00023210-200822070-00004. CNS Drugs. 2008. PMID: 18547127 Review.
Milnacipran versus other antidepressive agents for depression.
Nakagawa A, Watanabe N, Omori IM, Barbui C, Cipriani A, McGuire H, Churchill R, Furukawa TA. Nakagawa A, et al. Among authors: omori im. Cochrane Database Syst Rev. 2009 Jul 8;2009(3):CD006529. doi: 10.1002/14651858.CD006529.pub2. Cochrane Database Syst Rev. 2009. PMID: 19588396 Free PMC article. Review.
Fluvoxamine versus other anti-depressive agents for depression.
Omori IM, Watanabe N, Nakagawa A, Cipriani A, Barbui C, McGuire H, Churchill R, Furukawa TA. Omori IM, et al. Cochrane Database Syst Rev. 2010 Mar 17;(3):CD006114. doi: 10.1002/14651858.CD006114.pub2. Cochrane Database Syst Rev. 2010. PMID: 20238342 Free PMC article. Review.
29 results